[April 26, 2011]

Research and Markets: Ethicon Endo-Surgery Medical Device Company Intelligence Report 2011

Research and Markets (http://www.researchandmarkets.com/research/55f364/ethicon_endosurge) has announced the addition of the "Ethicon Endo-Surgery Medical Device Company Intelligence Report" report to their offering.

Ohio, US-based Ethicon Endo-Surgery Inc (EES) develops and markets advanced medical devices for minimally-invasive and open surgical procedures. The company's primary focus is on designing procedure-enabling devices for the interventional diagnosis and treatment of conditions in bariatric, breast, colorectal, ENT (ear, nose and throat), gynaecologic, orthopaedic, plastic, spine, thoracic and general surgery. In addition, the company's Advanced Sterilization Products (ASP) division produces solutions to help fight healthcare-associated infections (HAIs).

EES' portfolio of products includes: Endopath-, Echelon- and Proximate-branded surgical instruments, Harmonic (News - Alert) and EnSeal energy devices and the Realize gastric band. ASP's products include Sterrad Sterilisation Systems, Evotech Endoscope Cleaner and the Glosair Area Decontamination System. The atter system was added to the company's portfolio through the acquisition of Gloster Europe in November 2009 and created a new market for ASP.

In July 2010, EES sold its Breast Care business, which sold products such as the Mammotome Breast Biopsy System and tissue markers, after determining that these products were outside the scope of its future growth platforms.

EES has manufacturing sites in the US and Mexico, and sales and distribution offices in more than 50 countries. The company also operates the Endo-Surgery Institute, an educational facility in Cincinnati, Ohio, as well as additional training centres in Germany and Japan.

EES generated sales of almost US$4.76 billion in 2010. The company forms part of Johnson & Johnson's Medical Devices and Diagnostics business.

This company report provides

Overview:

• Key contact information
• Introduction to the company and its current activities
• Summary of its financial performance
• Who are the company's major competitors?
• Key recent events in an at a glance format

Financial Review:

• Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
• Table providing in-depth five-year financial analysis
• Employee data, including breakdown by company division and geographic location

Strategic Focus:

• Investigates the company's aims and its areas of focus

Products:

• Core product areas, key brands, product approvals and launches Research and Development
• How much has been invested in R&D?
• Where is the research based?
• What alliances and agreements does the company have and with whom?

Manufacturing and Distribution:

• Identifying the company's manufacturing locations
• Sales and marketing facilities

Agreements:

• With whom has the company reached agreements and what do they involve?
• Key contracts awarded

Mergers, Acquisitions, Minority Investments and Divestments

Litigation

Key Corporate Events

Companies Mentioned:

• Gloster Europe
• SurgRx
• InScope
• Obtech Medical
• Medtrex
• Biopsys Medical
• Indigo Medical
• UltraCision
• Cyberonics
• Neoprobe
• GE Healthcare
• Inamed (Allergan)
• Intuitive Surgical
• Termination of Agreement
• Given Imaging

For more information visit http://www.researchandmarkets.com/research/55f364/ethicon_endosurge

Source (News - Alert): Espicom Business Intelligence Ltd

[ Back To TMCnet.com's Homepage ]